247 related articles for article (PubMed ID: 31743245)
21. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
22. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Cutaneous Melanoma of the Head and Neck With Wide Local Excision Versus Mohs.
Namin AW; Oudin EM; Tassone PT; Galloway TLI; Dooley LM; Zitsch RP
Laryngoscope; 2021 Nov; 131(11):2490-2496. PubMed ID: 33844289
[TBL] [Abstract][Full Text] [Related]
24. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
Demer AM; Hanson JL; Maher IA; Liszewski W
JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
[TBL] [Abstract][Full Text] [Related]
25. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
Walling HW; Scupham RK; Bean AK; Ceilley RI
J Am Acad Dermatol; 2007 Oct; 57(4):659-64. PubMed ID: 17870430
[TBL] [Abstract][Full Text] [Related]
26. Mohs Surgery for SEER Registry-Captured Melanoma In Situ and Rare Cutaneous Tumors: Comparing National Utilization Patterns Before and After Implementation of the Affordable Care Act (2010) and Appropriate Use Criteria (2012).
Garland K; Condon S; Xiong DD; Crowe D; Knackstedt TJ
Dermatol Surg; 2020 Aug; 46(8):1021-1029. PubMed ID: 31929340
[TBL] [Abstract][Full Text] [Related]
27. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients.
Seo J; Oh Y; Kim SK; Roh MR; Chung KY
Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431
[TBL] [Abstract][Full Text] [Related]
28. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
29. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
30. Mohs micrographic surgery versus wide local excision for head and neck melanoma-
Phan K; Onggo J; Loya A
J Dermatolog Treat; 2020 Sep; 31(6):559-562. PubMed ID: 31264932
[No Abstract] [Full Text] [Related]
31. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
[TBL] [Abstract][Full Text] [Related]
32. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
33. Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.
Cheraghlou S; Christensen SR; Leffell DJ; Girardi M
JAMA Dermatol; 2021 May; 157(5):531-539. PubMed ID: 33787836
[TBL] [Abstract][Full Text] [Related]
34. Mohs micrographic surgery for the treatment of melanoma.
Hui AM; Jacobson M; Markowitz O; Brooks NA; Siegel DM
Dermatol Clin; 2012 Jul; 30(3):503-15. PubMed ID: 22800554
[TBL] [Abstract][Full Text] [Related]
35. Mohs Micrographic Surgery at Challenging Anatomical Sites.
Mori WS; Demer AM; Mattox AR; Maher IA
Dermatol Surg; 2019 Dec; 45 Suppl 2():S142-S154. PubMed ID: 31764299
[TBL] [Abstract][Full Text] [Related]
36. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
37. Patients prioritize local recurrence risk over other attributes for surgical treatment of facial melanomas-Results of a stated preference survey and choice-based conjoint analysis.
Etzkorn JR; Tuttle SD; Lim I; Feit EM; Sobanko JF; Shin TM; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Aug; 79(2):210-219.e3. PubMed ID: 29505861
[TBL] [Abstract][Full Text] [Related]
38. Mohs micrographic surgery for the treatment of malignant melanoma.
Whalen J; Leone D
Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
[TBL] [Abstract][Full Text] [Related]
39. Mohs micrographic surgery challenges and new technologies to optimize care of cutaneous malignancies of the ear.
Colao B; Khachemoune A
Arch Dermatol Res; 2024 Jun; 316(6):320. PubMed ID: 38822894
[TBL] [Abstract][Full Text] [Related]
40. Cylindroma treated by Mohs micrographic surgery.
Lo JS; Snow SN; Mohs FE
J Dermatol Surg Oncol; 1991 Nov; 17(11):871-4. PubMed ID: 1661754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
